Marshall Wace’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-651,906
| Closed | -$430K | – | 2948 |
|
|
2025
Q1 | $430K | Buy |
651,906
+314,776
| +93% | +$208K | ﹤0.01% | 2023 |
|
|
2024
Q4 | $344K | Sell |
337,130
-2,016,626
| -86% | -$2.06M | ﹤0.01% | 2046 |
|
|
2024
Q3 | $2.05M | Buy |
2,353,756
+1,777,537
| +308% | +$1.55M | ﹤0.01% | 1254 |
|
|
2024
Q2 | $207K | Buy |
576,219
+207,476
| +56% | +$74.7K | ﹤0.01% | 2083 |
|
|
2024
Q1 | $247K | Buy |
+368,743
| New | +$247K | ﹤0.01% | 1907 |
|
|
2020
Q4 | – | Sell |
-11,127
| Closed | -$105K | – | 2007 |
|
|
2020
Q3 | $105K | Buy |
+11,127
| New | +$105K | ﹤0.01% | 1477 |
|
|
2020
Q2 | – | Sell |
-1,363,039
| Closed | -$8.68M | – | 1867 |
|
|
2020
Q1 | $8.68M | Buy |
1,363,039
+1,033,713
| +314% | +$6.59M | 0.09% | 235 |
|
|
2019
Q4 | $2.76M | Buy |
329,326
+296,968
| +918% | +$2.49M | 0.02% | 680 |
|
|
2019
Q3 | $293K | Buy |
+32,358
| New | +$293K | ﹤0.01% | 1167 |
|
|
2019
Q1 | – | Sell |
-712,657
| Closed | -$8.18M | – | 2017 |
|
|
2018
Q4 | $8.18M | Buy |
712,657
+699,089
| +5,152% | +$8.03M | 0.08% | 299 |
|
|
2018
Q3 | $230K | Buy |
+13,568
| New | +$230K | ﹤0.01% | 1046 |
|
|
2017
Q3 | – | Sell |
-56,314
| Closed | -$507K | – | 409 |
|
|
2017
Q2 | $507K | Buy |
+56,314
| New | +$507K | 0.02% | 240 |
|